Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I
Unger, Joseph M, Qian, Lu, Redman, Mary W, Tavernier, Susan S, Minasian, Lori, Sigal, Ellen V, Papadimitrakopoulou, Vassiliki A, Leblanc, Michael, Cleeland, Charles S, Dzingle, Samuel A, Summers, Thomas J, Chao, Herta, Madhusudhana, Sheshadri, Villaruz, Liza, Crawford, Jeffrey, Gray, Jhanelle E, Kelly, Karen L, Gandara, David R, Bazhenova, Lyudmila, Herbst, Roy S, Gettinger, Scott N, Moinpour, Carol M
Published in JNCI : Journal of the National Cancer Institute (11.04.2023)
Published in JNCI : Journal of the National Cancer Institute (11.04.2023)
Get full text
Journal Article